Market Highlights
- AGC Biologics laid off 68 employees at its cell and gene therapy plant in Longmont and 17 employees at its commercial mammalian plant in Boulder.
- Ambrosia Biosciences has secured $16.0 million in Series A financing to scale up its drug discovery programs and laboratory operations in Boulder.
- Sterling Bay has received approval for the Redtail Ridge Innovation District in Louisville, featuring a mixed-use campus with life sciences, R&D, cGMP manufacturing, office and retail spaces.